AAAAAA

   
Results: 1-14 |
Results: 14
ARGATROBAN STRONGLY REDUCES THROMBUS FORMATION UNDER FLOW CONDITIONS IN HUMANS
Authors: MELANDRI G SEMPRINI F DESCOVICH B CERVI V BRANZI A
Citation: G. Melandri et al., ARGATROBAN STRONGLY REDUCES THROMBUS FORMATION UNDER FLOW CONDITIONS IN HUMANS, Thrombosis and haemostasis, 1997, pp. 784-784
RECURRENT ANGINA-PECTORIS AFTER THROMBOLYSIS - ANGIOGRAPHIC CORRELATES AND EVOLUTION IN THE WAAT TRIAL
Authors: MELANDRI G CANDIOTTI N SEMPRINI F DESCOVICH B REGGIANI LB BRANZI A MAGNANI B
Citation: G. Melandri et al., RECURRENT ANGINA-PECTORIS AFTER THROMBOLYSIS - ANGIOGRAPHIC CORRELATES AND EVOLUTION IN THE WAAT TRIAL, Thrombosis and haemostasis, 1997, pp. 2886-2886
EFFECT OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE ON BLOOD-COAGULATION,CLOT-BOUND THROMBIN AND PLATELET DEPOSITION AT LOW AND HIGH-SHEAR RATES
Authors: MELANDRI G SEMPRINI F CERVI V BOSCHI S CANDIOTTI N BRANZI A MAGNANI B
Citation: G. Melandri et al., EFFECT OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE ON BLOOD-COAGULATION,CLOT-BOUND THROMBIN AND PLATELET DEPOSITION AT LOW AND HIGH-SHEAR RATES, Journal of the American College of Cardiology, 1994, pp. 10000260-10000260
PHARMACODYNAMIC CHARACTERISTICS OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AFTER SUBCUTANEOUS ADMINISTRATION IN ACUTE MYOCARDIAL-INFARCTION
Authors: TRAINI AM CERVI V MELANDRI G PALAZZINI E ZAMBONI V SEMPRINI F CANDIOTTI N BRANZI A
Citation: Am. Traini et al., PHARMACODYNAMIC CHARACTERISTICS OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AFTER SUBCUTANEOUS ADMINISTRATION IN ACUTE MYOCARDIAL-INFARCTION, Journal of international medical research, 22(6), 1994, pp. 323-331
PLATELET-VESSEL WALL INTERACTION UNDER FLOW CONDITIONS IS INHIBITED BY THE DUAL THROMBOXANE INHIBITOR THROMBOXANE-A2 RECEPTOR ANTAGONIST PICOTAMIDE IN HUMANS
Authors: MELANDRI G SEMPRINI F CERVI V DESCOVICH B BRANZI A MAGNANI B
Citation: G. Melandri et al., PLATELET-VESSEL WALL INTERACTION UNDER FLOW CONDITIONS IS INHIBITED BY THE DUAL THROMBOXANE INHIBITOR THROMBOXANE-A2 RECEPTOR ANTAGONIST PICOTAMIDE IN HUMANS, Circulation, 90(4), 1994, pp. 181-181
PLATELET-VESSEL WALL INTERACTION UNDER FLOW CONDITIONS IS INHIBITED BY THE DUAL THROMBOXANE INHIBITOR THROMBOXANE-A2 RECEPTOR ANTAGONIST PICOTAMIDE IN HUMANS
Authors: MELANDRI G SEMPRINI F CERVI V DESCOVICH B BRANZI A MAGNANI B
Citation: G. Melandri et al., PLATELET-VESSEL WALL INTERACTION UNDER FLOW CONDITIONS IS INHIBITED BY THE DUAL THROMBOXANE INHIBITOR THROMBOXANE-A2 RECEPTOR ANTAGONIST PICOTAMIDE IN HUMANS, Circulation, 90(4), 1994, pp. 181-181
NEUROCIRCULATORY ASTHENIA - A REASSESSMENT USING MODERN PSYCHOSOMATICCRITERIA
Authors: FAVA GA MAGELLI C SAVRON G CONTI S BARTOLUCCI G GRANDI S SEMPRINI F SAVIOTTI FM BELLUARDO P MAGNANI B
Citation: Ga. Fava et al., NEUROCIRCULATORY ASTHENIA - A REASSESSMENT USING MODERN PSYCHOSOMATICCRITERIA, Acta psychiatrica Scandinavica, 89(5), 1994, pp. 314-319
STABLE AND UNSTABLE ANGINA-PECTORIS
Authors: BRANZI A MELANDRI G SEMPRINI F CERVI V TRAINI AM CANDIOTTI N BOSCHI S
Citation: A. Branzi et al., STABLE AND UNSTABLE ANGINA-PECTORIS, Platelets, 4, 1993, pp. 23-24
THE INACTIVATION OF FLUID-PHASE AND CLOT BOUND THROMBIN BY LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AND HEPARIN IS BETTER RELATED WITH THE HEPTEST THAN WITH THE APTT
Authors: MELANDRI G SEMPRINI F CERVI V CANDIOTTI N BOSCHI S BRANZI A MAGNANI B
Citation: G. Melandri et al., THE INACTIVATION OF FLUID-PHASE AND CLOT BOUND THROMBIN BY LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AND HEPARIN IS BETTER RELATED WITH THE HEPTEST THAN WITH THE APTT, Thrombosis and haemostasis, 69(6), 1993, pp. 891-891
EFFECTS OF HEPARIN (H) AND LOW-MOLECULAR-WEIGHT DERMATAN-SULFATE (D) ON CLOT-BOUND (CT) VS FLUID-PHASE THROMBIN (FT)
Authors: SEMPRINI F MELANDRI G CANDIOTTI N CERVI V BRANZI A MAGNANI B
Citation: F. Semprini et al., EFFECTS OF HEPARIN (H) AND LOW-MOLECULAR-WEIGHT DERMATAN-SULFATE (D) ON CLOT-BOUND (CT) VS FLUID-PHASE THROMBIN (FT), Thrombosis research, 70, 1993, pp. 72-72
LOW-MOLECULAR-WEIGHT HEPARIN IS MORE ACTIVE THAN UNFRACTIONATED HEPARIN IN PLATELET-RICH ENVIRONMENTS
Authors: SEMPRINI F MELANDRI G CANDIOTTI N CERVI V BRANZI A MAGNANI B
Citation: F. Semprini et al., LOW-MOLECULAR-WEIGHT HEPARIN IS MORE ACTIVE THAN UNFRACTIONATED HEPARIN IN PLATELET-RICH ENVIRONMENTS, Thrombosis research, 70, 1993, pp. 135-135
EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN(PARNAPARIN) ON EXERCISE TOLERANCE IN CHRONIC, STABLE ANGINA
Authors: MELANDRI G SEMPRINI F CERVI V CANDIOTTI N BRANZI A MAGNANI B
Citation: G. Melandri et al., EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN(PARNAPARIN) ON EXERCISE TOLERANCE IN CHRONIC, STABLE ANGINA, Thrombosis research, 70, 1993, pp. 135-135
BENEFIT OF ADDING LOW-MOLECULAR-WEIGHT HEPARIN TO THE CONVENTIONAL TREATMENT OF STABLE ANGINA-PECTORIS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Authors: MELANDRI G SEMPRINI F CERVI V CANDIOTTI N PALAZZINI E BRANZI A MAGNANI B
Citation: G. Melandri et al., BENEFIT OF ADDING LOW-MOLECULAR-WEIGHT HEPARIN TO THE CONVENTIONAL TREATMENT OF STABLE ANGINA-PECTORIS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Circulation, 88(6), 1993, pp. 2517-2523
COMPARISON OF EFFICACY OF LOW-MOLECULAR-WEIGHT HEPARIN (PARNAPARIN) WITH THAT OF UNFRACTIONATED HEPARIN IN THE PRESENCE OF ACTIVATED PLATELETS IN HEALTHY-SUBJECTS
Authors: MELANDRI G SEMPRINI F CERVI V CANDIOTTI N BRANZI A PALAZZINI E MAGNANI B
Citation: G. Melandri et al., COMPARISON OF EFFICACY OF LOW-MOLECULAR-WEIGHT HEPARIN (PARNAPARIN) WITH THAT OF UNFRACTIONATED HEPARIN IN THE PRESENCE OF ACTIVATED PLATELETS IN HEALTHY-SUBJECTS, The American journal of cardiology, 72(5), 1993, pp. 450-454
Risultati: 1-14 |